San Francisco Sentry Investment Group’s Teladoc Health TDOC Stock Holding History

San Francisco Sentry Investment Group’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$56K	Hold	335	–	–	0.03%	350
2021 Q1	$61K	Hold	335	–	–	0.03%	357
2020 Q4	$67K	Hold	335	–	–	0.03%	322
2020 Q3	$73K	Sell	335 -1,750	-84%	-$371K	0.04%	292
2020 Q2	$398K	Buy	+2,085	New	+$365K	0.21%	106

Other funds holding TDOC

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

GCGM

General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

San Francisco Sentry Investment Group's TDOC Position: Q2 2021 in Review

San Francisco Sentry Investment Group held its Teladoc Health (TDOC) position steady in Q2 2021 at 335 shares worth $56K. The position accounts for 0.03% of the portfolio, ranked #350.

San Francisco Sentry Investment Group first reported a position in TDOC in Q2 2020 and has held it in 5 quarters since. The position peaked at $398K in Q2 2020. 829 funds tracked by Wall St. Rank hold TDOC as of Q2 2021.

San Francisco Sentry Investment Group held 335 shares of Teladoc Health worth $56K as of Q2 2021.
San Francisco Sentry Investment Group left its Teladoc Health share count unchanged in Q2 2021.
Teladoc Health made up 0.03% of San Francisco Sentry Investment Group's portfolio in Q2 2021, its #350 holding.
San Francisco Sentry Investment Group first reported a position in Teladoc Health in Q2 2020 and has held it in 5 quarters since.
San Francisco Sentry Investment Group's Teladoc Health position peaked at $398K in Q2 2020.
829 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2021.

Based on San Francisco Sentry Investment Group's 13F filing for Q2 2021, filed 2 Aug 2021.